Loading clinical trials...
Loading clinical trials...
The Efficacy of Botulinum Toxin Type a in Treating Peyronie's Disease
Conditions
Interventions
100 units of Botulinum Toxin Type A
Preservative free normal saline
+1 more
Locations
1
United States
Baylor College of Medicine
Houston, Texas, United States
Start Date
August 7, 2009
Primary Completion Date
February 15, 2017
Completion Date
January 15, 2019
Last Updated
April 8, 2024
Lead Sponsor
Mohit Khera
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions